ConductScience.org, home

Paper1382018

Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.

Todd PA and 1 other. Drugs, 1992. Cited by 66 papers, by iCite.

Cite this record

ConductScience Library. Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders. Papers, record 1382018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1382018

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.
PubMed
Journal
Drugs
PubMed
Year
1992
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Review
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
2.75
iCite
Revised in PubMed
2026-10-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Todd PAP A
2Faulds DD

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angina PectorisMajor topic
FelodipineMajor topic
Heart FailureMajor topic
HypertensionMajor topic
Cardiomegaly
Delayed-Action Preparations
Diabetes Mellitus, Type 2
Drug Interactions
Drug Therapy, Combination
Humans

Source PubMed

Download CSV of topics

References105

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12083195Hemodynamic interactions between diuretics and calcium antagonists in the treatment of hypertensive patients.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2083195PubMed
22015166A population study of the pharmacokinetics of felodipine.Br J Clin Pharmacol1991https://conductscience.org/library/papers/2015166PubMed
32404502Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets.Br J Clin Pharmacol1990https://conductscience.org/library/papers/2404502PubMed
41748135Comparison of once daily felodipine 10 mg ER and hydrochlorothiazide 25 mg in the treatment of mild to moderate hypertension.Eur J Clin Pharmacol1991https://conductscience.org/library/papers/1748135PubMed
52676559The clinical effect of felodipine and nifedipine in Raynaud's phenomenon.Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2676559PubMed
62656902Effects of felodipine on plasma digoxin levels and haemodynamics in patients with heart failure.J Intern Med1989https://conductscience.org/library/papers/2656902PubMed
72532135Effect of felodipine, a new calcium channel antagonist, on platelet function and fibrinolytic activity at rest and after exercise.Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2532135PubMed
81991673Acute and chronic efficacy of felodipine in congestive heart failure.Int J Cardiol1991https://conductscience.org/library/papers/1991673PubMed
91704983Antihypertensive efficacy and tolerability of a fixed combination of metoprolol and felodipine in comparison with the individual substances in monotherapy. The Swedish/United Kingdom Study Group.J Cardiovasc Pharmacol1990https://conductscience.org/library/papers/1704983PubMed
102151392Reversal of cardiac hypertrophy and left ventricular function with the calcium antagonist felodipine in hypertensive patients.J Hum Hypertens1990https://conductscience.org/library/papers/2151392PubMed
112095339The haemodynamic effects of long term felodipine therapy in previously untreated essential hypertension.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/2095339PubMed
121531566Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy.Am J Cardiol1992https://conductscience.org/library/papers/1531566PubMed
131874870Determination of felodipine and its metabolites in plasma using capillary gas chromatography with electron-capture detection and their identification by gas chromatography-mass spectrometry.J Chromatogr1991https://conductscience.org/library/papers/1874870PubMed
142282920Felodipine in chronic stable angina: a randomized, double-blind, placebo-controlled, crossover study.Eur Heart J1990https://conductscience.org/library/papers/2282920PubMed
152702968Increased exercise tolerance and reduced electrocardiographic ischaemia 3 and 12 hours after oral felodipine in effort angina.Eur Heart J1989https://conductscience.org/library/papers/2702968PubMed
162706189Pharmacokinetics of felodipine in patients with impaired renal function.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2706189PubMed
172311731The use of a vasodilator, felodipine, as an adjuvant to long-term oxygen treatment in COLD patients.Eur Respir J1990https://conductscience.org/library/papers/2311731PubMed
181693714The effect of felodipine on cold-induced digital vasospasm.J Cardiovasc Pharmacol1990https://conductscience.org/library/papers/1693714PubMed
191283578Does a reduction in left ventricular hypertrophy reduce cardiovascular morbidity and mortality?Drugs1992https://conductscience.org/library/papers/1283578PubMed
201614069Renal effects of felodipine--a review.Kidney Int Suppl1992https://conductscience.org/library/papers/1614069PubMed

See all 105 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
42722786Self-Nanoemulsifying Drug Delivery Systems for Cardiovascular Therapeutics: Formulation Strategies, Pharmacokinetic Enhancement and Precision-Oriented Translation.J Cardiovasc Transl Res2026https://conductscience.org/library/papers/42722786PubMed
40940752Beyond Support Cells: Astrocytic Autophagy as a Central Regulator of CNS Homeostasis and Neurodegenerative Diseases.Cells2025https://conductscience.org/library/papers/40940752PubMed
40259510Felodipine Promotes the Recovery of Mice With Spinal Cord Injury by Activating Macrolipophagy Through the AMPK-mTOR Pathway.J Cell Mol Med2025https://conductscience.org/library/papers/40259510PubMed
40087313Enhancing solubility and dissolution of felodipine using self-nanoemulsifying drug systems through in vitro evaluation.Sci Rep2025https://conductscience.org/library/papers/40087313PubMed
36415635Lipid-Polymer Hybrid Nanocarriers for Oral Delivery of Felodipine: Formulation, Characterization and Ex Vivo Evaluation.Adv Pharm Bull2022https://conductscience.org/library/papers/36415635PubMed
35310349Felodipine enhances aminoglycosides efficacy against implant infections caused by methicillin-resistant Staphylococcus aureus, persisters and biofilms.Bioact Mater2022https://conductscience.org/library/papers/35310349PubMed
30624988Potential Strategies to Reduce Blood Pressure in Treatment-Resistant Hypertension Using Food and Drug Administration-Approved Nanodrug Delivery Platforms.Hypertension2019https://conductscience.org/library/papers/30624988PubMed
29197935How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension.High Blood Press Cardiovasc Prev2018https://conductscience.org/library/papers/29197935PubMed
24936117Effects of low-dose treatment with felodipine versus fosinopril in Chinese patients with nonischemic heart failure and normal blood pressure: A double-blind, randomized, crossover study.Curr Ther Res Clin Exp2004https://conductscience.org/library/papers/24936117PubMed
16114982Ramipril/felodipine extended-release fixed-dose combination: a review of its use in the management of essential hypertension.Drugs2005https://conductscience.org/library/papers/16114982PubMed
14984260Bioavailability prediction based on molecular structure for a diverse series of drugs.Pharm Res2004https://conductscience.org/library/papers/14984260PubMed
10718104Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension.Drugs2000https://conductscience.org/library/papers/10718104PubMed
10147441Enalapril: a review of quality-of-life and pharmacoeconomic aspects of its use in heart failure and mild to moderate hypertension.Pharmacoeconomics1994https://conductscience.org/library/papers/10147441PubMed
9646008Clinical pharmacokinetics of vasodilators. Part I.Clin Pharmacokinet1998https://conductscience.org/library/papers/9646008PubMed
8665991Clinical equivalence of two tablet formulations of felodipine. A placebo-controlled study of 24-hour blood pressure control and tolerability.Eur J Clin Pharmacol1995https://conductscience.org/library/papers/8665991PubMed
8521768Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metoprolol.Drugs1995https://conductscience.org/library/papers/8521768PubMed
7741985Controlled release drugs in overdose. Clinical considerations.Drug Saf1995https://conductscience.org/library/papers/7741985PubMed
7620235Nimodipine. Potential for drug-drug interactions in the elderly.Drugs Aging1995https://conductscience.org/library/papers/7620235PubMed
7574861A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension.Arch Dis Child1995https://conductscience.org/library/papers/7574861PubMed
1392220Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients.Drugs Aging1992https://conductscience.org/library/papers/1392220PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1382018

GET https://conductscience.org/api/papers/v1/1382018/references?page=2